MR-guided RT

Global Radiotherapy Impact Report

Proud to support leading voices in oncology who are showcasing radiotherapy’s impact worldwide.

Iconographic - globally 1.47M diagnoses each year

Prostate cancer

Shorter courses, greater precision, preserved function. Clinical evidence shows how daily adaptation improves accuracy and long-term outcomes.

Iconographic - incidence is expected to rise by over 70% by 2040

Gynecological cancers

Treating gynecological cancers requires precision and care. Image-guided radiotherapy and brachytherapy adapt to pelvic changes while protecting healthy tissue.

Iconographic - globally only 10% people survive five years

Pancreatic cancer

Evidence shows how adaptive radiotherapy can deliver high-dose treatment safely and extend survival, offering new hope in one of the hardest cancers to treat.

Adaptive radiotherapy

The new standard of care

For more than 50 years, Elekta has advanced precision in cancer care. Now we’re leading the way in making adaptive radiotherapy a practical standard of care for clinics everywhere.

Hope for everyone
dealing with cancer.

At Elekta, we're inspired because every difference—from the smallest tumor change to the greatest clinical challenge—is a chance to innovate together, advance care, and set new standards that make a meaningful impact on lives.

Press Releases

Smiling coworkers connecting with each other

Choose a career with us

We don't just build technology,
we build hope